Visit
CAR-T Meeting 2022
What a pleasant surprise to see my @CccLmu @LMU_Muenchen colleague @KRejeski pop up on @VJHemOnc discussing the CAR-HEMATOTOX score developed by our departments @LMU_Immutherapy group led by @MSubklewe .
@OncoAlert 🚨 #hematology https://twitter.com/VJHemOnc/status/1482382472482639873
@VJHemOnc caught up w/ @KRejeski of @LMU_Muenchen on the use of the CAR-HEMATOTOX score to identify patients who are at risk of non-relapse mortality post #CART
Hear more on the team’s interesting findings: http://ow.ly/tCMO50HuuBz
#ASH21 @ASH_hematology #HemOnc #ImmunoOnc
Thank you @VJHemOnc for the opportunity! https://www.vjhemonc.com/speaker/raffaele-palmieri/ https://twitter.com/vjhemonc/status/1640399029552005132
Last week, we had the pleasure of being in Munich at #ISAL2023, interviewing experts in AML and ALL, who shared some interesting insights & updates.
Check out our interviews here:
🎥: http://ow.ly/xjOL50MWU55
#AMLsm #ALLsm #LeuSM #ImmunoOnc #HemOnc #ISALXVIII
#ISAL2023 | @RaviMajetiMD of @Stanford shares some insights into how epigenetic analysis may be used to better understand the biology of relapse in patients with AML.
Watch here:
👉http://ow.ly/aqBN50Nr42B👈
#AMLsm #LeuSM #HemOnc
CAR-T Meeting 2022
What a pleasant surprise to see my @CccLmu @LMU_Muenchen colleague @KRejeski pop up on @VJHemOnc discussing the CAR-HEMATOTOX score developed by our departments @LMU_Immutherapy group led by @MSubklewe .
@OncoAlert 🚨 #hematology https://twitter.com/VJHemOnc/status/1482382472482639873
@VJHemOnc caught up w/ @KRejeski of @LMU_Muenchen on the use of the CAR-HEMATOTOX score to identify patients who are at risk of non-relapse mortality post #CART
Hear more on the team’s interesting findings: http://ow.ly/tCMO50HuuBz
#ASH21 @ASH_hematology #HemOnc #ImmunoOnc
Thank you @VJHemOnc for the opportunity! https://www.vjhemonc.com/speaker/raffaele-palmieri/ https://twitter.com/vjhemonc/status/1640399029552005132
Last week, we had the pleasure of being in Munich at #ISAL2023, interviewing experts in AML and ALL, who shared some interesting insights & updates.
Check out our interviews here:
🎥: http://ow.ly/xjOL50MWU55
#AMLsm #ALLsm #LeuSM #ImmunoOnc #HemOnc #ISALXVIII
#ISAL2023 | @RaviMajetiMD of @Stanford shares some insights into how epigenetic analysis may be used to better understand the biology of relapse in patients with AML.
Watch here:
👉http://ow.ly/aqBN50Nr42B👈
#AMLsm #LeuSM #HemOnc
VJHemOnc is intended for Healthcare Professionals only
By choosing to continue, you are confirming that you are a healthcare professional
Sign-up for our Newsletter!
Keep up to date with all the latest news with our monthly newsletter
